Interferon gamma signaling
基因
试剂
文献样例
产品评述样例
2 5 oligoadenylate synthetase like
2'-5'-oligoadenylate synthetase like
B2M
beta-2-microglobulin
总数:5
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression. 2008 至该文献
为了研究特定人群的肿瘤浸润淋巴细胞在诊断原发性黑色素瘤切片检查中的出现可以鉴定为临床阶段Ⅱ期黑色素瘤病人，采用了Dako的B2m的抗体进行了免疫组化实验。 更多
CAMK2A
calcium/calmodulin dependent protein kinase II alpha
总数:13
Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. 2009 至该文献
为了研究CaMKII在调控血压过载诱导的小鼠心肌肥厚到心脏衰竭中的作用，采用了Affinity Bioreagents公司的抗磷酸化CaMKII抗体产品 ，进行了免疫印迹实验 更多
CAMK2D
calcium/calmodulin dependent protein kinase II delta
CAMK2G
calcium/calmodulin dependent protein kinase II gamma
总数:10
Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2. 2010 至该文献
为了研究cGMP依赖的蛋白激酶和RGS2在心钠素抵抗局部肥大中的作用，采用了Santa Cruz公司的抗磷酸化CaMKII抗体，进行western blot实验。 更多
CD44
CD44 molecule (Indian blood group)
总数:49
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1. 2013 至该文献
为了在小鼠模型中研究sFlt-1对于维持无血管感光层的作用，Millipore的大鼠抗硫酸肝素蛋白多糖单克隆抗体被用于进行免疫组化实验。 更多
CD56
neural cell adhesion molecule 1
总数:56
Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. 2012 至该文献
为了研究共生菌被先天淋巴细胞限定在特定的位置，采用了eBioscience的eFluor780标记的CD56抗体进行流式细胞分选实验。 更多
CD64
Fc fragment of IgG receptor Ia
总数:15
PPAR? controls Dectin-1 expression required for host antifungal defense against Candida albicans. 2010 至该文献
为了研究PPARgamm在调控dectin-1的表达和宿主抗真菌防御中的作用，采用了Serotec公司的抗F4/80抗体产品，进行了流式细胞分析实验。 更多
CIITA
class II major histocompatibility complex transactivator
总数:5
A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophages. 2009 至该文献
为了研究JAK-STAT1通道在调控HSV-1复制中的作用，使用了Biolegend公司的抗MHC class II-APC 抗体，来收集和染色受感染的细胞，进行了流式细胞计量实验。 更多
DPB1
major histocompatibility complex, class II, DP beta 1
GBP 5 (GBP 5)
guanylate binding protein 5
总数:1
GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals. 2012 至该文献
为了研究哺乳动物中NLRP3炎性体能被GBP5调控，采用了SantaCruz的山羊抗GBP5抗体进行蛋白印迹实验。
GBP1
guanylate binding protein 1
GBP2
guanylate binding protein 2
GBP3
guanylate binding protein 3
GBP4
guanylate binding protein 4
GBP6
guanylate binding protein family member 6
GBP7
guanylate binding protein 7
GILT
IFI30 lysosomal thiol reductase
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
HLA E (HLA E)
major histocompatibility complex, class I, E
总数:12
ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. 2012 至该文献
为了研究ESCRT-III调控Aurora B介导的细胞脱落，采用了Serotec的FITC标记的抗MHC-I抗体进行流式细胞分选实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用，采用了Santa Cruz Biotechnology HLA-A（A-18)抗体进行了免疫组化实验。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用，采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-DQA2 (HLA-DQA2)
major histocompatibility complex, class II, DQ alpha 2
HLA-DQB1 (HLA-DQB1)
major histocompatibility complex, class II, DQ beta 1
总数:1
Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma. 2007 至该文献
为了研究CD80和CD86可能作为鼻咽癌预后的标记物，采用Novocastra Laboratories的抗HLA Class II (DR)抗体进行免疫组织化学实验。
HLA-DQB2 (HLA-DQB2)
major histocompatibility complex, class II, DQ beta 2
总数:1
Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background. 2010 至该文献
为了研究HLA-DQ2在相关的免疫病变病理过程中的作用，采用了Becton Dickinson的抗DQ（TU39）抗体进行流式细胞术。
HLA-DR (HLA-DR)
major histocompatibility complex, class II, DR alpha
总数:22
Tolerance induced via TLR2 and TLR4 in human dendritic cells: role of IRAK-1. 2008 至该文献
为了研究IRAK-1信号阻断对TLR2和TLR4诱导的人树突状细胞耐受有重要作用，采用Beckman-Coulter的抗HLA DR- PC5抗体进行流式细胞分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析，采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析，采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析，采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析，采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析，采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析，采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析，采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析，采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析，采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析，采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析，采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB3 (HLA-DRB3)
major histocompatibility complex, class II, DR beta 3
HLA-DRB4 (HLA-DRB4)
major histocompatibility complex, class II, DR beta 4
HLA-DRB4 (HLA-DRB4)
major histocompatibility complex, class II, DR beta 4
HLA-DRB5 (HLA-DRB5)
major histocompatibility complex, class II, DR beta 5
总数:2
Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. 2008 至该文献
HLA-DRB5 (HLA-DRB5)
major histocompatibility complex, class II, DR beta 5
总数:2
Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. 2008 至该文献
HLA-F (HLA-F)
major histocompatibility complex, class I, F
总数:1
Progressive myopathy and defects in the maintenance of myotendinous junctions in mice that lack talin 1 in skeletal muscle. 2008 至该文献
为了研究talin 1在骨骼肌发育和功能中的作用，采用了Sigma的鼠抗MHCf单抗，进行免疫组化实验
ICAM-1 (ICAM-1)
intercellular adhesion molecule 1
总数:30
Remodelling of cortical actin where lytic granules dock at natural killer cell immune synapses revealed by super-resolution microscopy. 2011 至该文献
为了研究在天然杀伤细胞免疫突触处皮质肌动蛋白的重塑，采用了R&D systems的抗ICAM-1抗体进行免疫细胞化学实验。 更多
IFN丙 (IFN-gamma)
interferon gamma
总数:62
The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. 2011 至该文献
为了研究血脑屏障的完整性和中枢神经免疫沉默能够被Shh信号通路促进，采用R&D Systems的抗IFN-gamma抗体以5ug/ml浓度进行细胞刺激实验。 更多
IFNGR1
interferon gamma receptor 1
总数:5
Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. 2008 至该文献
为研究人骨髓MSCs表达的TLR3和TLR4对抑制其T细胞调节活性的作用，采用了BD Biosciences公司的抗CD119单克隆抗体进行流式细胞术试验。 更多
IRF-1 (IRF-1)
interferon regulatory factor 1
总数:14
Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes. 2008 至该文献
为研究干扰素调控因子4(IRF-4)在EBV病毒感染人类B淋巴细胞中的作用，采用了Santa Cruz Biotechnology公司的抗IRF-1抗体进行蛋白质印迹试验。 更多
IRF-2 (IRF-2)
interferon regulatory factor 2
总数:7
Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes. 2008 至该文献
为研究干扰素调控因子4(IRF-4)在EBV病毒感染人类B淋巴细胞中的作用，采用了Santa Cruz Biotechnology公司的抗IRF-2抗体进行蛋白质印迹试验。 更多
IRF-3 (IRF-3)
interferon regulatory factor 3
总数:22
DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. 2012 至该文献
为了研究IRF-3依赖的先天性免疫反应，采用了Life Technologies 的抗IRF-3抗体进行了蛋白免疫印迹实验。 更多
IRF4
interferon regulatory factor 4
总数:6
Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma. 2009 至该文献
为从222例症状明显的伯基特淋巴瘤患者中分析其MUM1, bcl-6 和CD138的表达模式与EBV的相关性，将Dako提供的抗MUM-1/IRF4抗体（克隆：MUM1P）用于免疫组织化学实验中。 更多
IRF5
interferon regulatory factor 5
总数:1
Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression. 2010 至该文献
为了说明IRF5同HATs和HDACs一起调控促炎细胞因子的转录水平表达，使用了Abcam公司的山羊抗IRF5多克隆抗体进行免疫共沉淀实验。
IRF6
interferon regulatory factor 6
总数:3
Human ?-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. 2012 至该文献
为了研究粘膜初级免疫受HD6自组装促进，采用了Difco的抗LPS抗体进行免疫细胞化学实验。 更多
IRF7
interferon regulatory factor 7
总数:4
Activation of anti-hepatitis C virus responses via Toll-like receptor 7. 2006 至该文献
为了研究Toll样受体7抵抗丙型肝炎病毒的机制，使用Santa Cruz公司抗IRF-7抗体进行western blot实验。 更多
IRF8
interferon regulatory factor 8
总数:4
IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. 2006 至该文献
IRF9
interferon regulatory factor 9
总数:1
Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA. 2008 至该文献
为了说明SeV C蛋白可以抑制双链RNA的产生来限制PKR的激活，使用了Santa Cruz Biotechnology公司的抗IRF9抗体来进行蛋白印迹实验。
Jak1
Janus kinase 1
总数:22
Identification of human thioredoxin as a novel IFN-gamma-induced factor: mechanism of induction and its role in cytokine production. 2008 至该文献
为了研究thioredoxin是受IFN-gamma诱导的因子并在细胞因子产生过程中起作用，采用Santa Cruz的抗Jak1和抗磷酸化Jak1抗体进行蛋白印迹实验。 更多
Janus激酶2 (Jak2)
Janus kinase 2
总数:34
Covering a broad dynamic range: information processing at the erythropoietin receptor. 2010 至该文献
为了确定在受体信号激活过程中促红细胞生成素受体的受体因素，使用了Upstate公司的抗JAK2抗体来进行免疫沉淀实验和免疫印记分析。 更多
OAS1
2'-5'-oligoadenylate synthetase 1
总数:2
A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L. 2007 至该文献
为了研究脊髓灰质炎病毒3C蛋白酶开放阅读框的一个RNA结构的作用，采用Abgent公司的抗OAS1多克隆抗体进行免疫印迹实验。 更多
OAS2
2'-5'-oligoadenylate synthetase 2
OAS3
2'-5'-oligoadenylate synthetase 3
PIAS1
protein inhibitor of activated STAT 1
总数:3
Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone. 2006 至该文献
为了研究cAMP信号介导的小类泛素修饰因子旁路的动态变化决定子宫内膜对孕酮反应的过程，采用了Santa Cruz Biotechnology的抗PIAS1(8152)抗体进行免疫印迹试验。 更多
PKC delta
protein kinase C delta
总数:35
PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1. 2009 至该文献
为了研究在肠部PKCα抑制肿瘤的机制，采用了Santa Cruz Biotechnology公司的抗PKCδ抗体，进行了蛋白质印迹实验。 更多
血小板活化因子受体 (platelet activating factor receptor)
总数:1
Relative levels of semen platelet activating factor-receptor (PAFr) and ubiquitin in yearling bulls with high content of semen white blood cells: implications for breeding soundness evaluation. 2007 至该文献
为研究血小板活化因子(PAF)受体在生育中的作用，采用Cayman 公司生产的 PAF受体抗体用于免疫印迹和免疫细胞化学实验。
前髓细胞性白血病蛋白 (PML)
promyelocytic leukemia
总数:43
The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. 2010 至该文献
为了阐明DAXX作为组蛋白的分子伴侣参与不依赖复制的H3.3组装，采用Santa Cruz Biotechnology的抗PML抗体进行免疫细胞化学实验。 更多
PTPN2
protein tyrosine phosphatase non-receptor type 2
总数:2
MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic beta-cell responses to the viral by-product double-stranded RNA. 2010 至该文献
为了研究MDA5 和PTPN2在调节胰岛beta细胞对病毒双链RNA副产物的反应中的作用，采用了R&D Systems公司的抗PTPN2抗体产品，进行了免疫印迹实验。 更多
SHP-1 (SHP-1)
protein tyrosine phosphatase non-receptor type 6
总数:16
The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo. 2009 至该文献
为了说明Lyn能抑制破骨细胞的形成，使用了Santa Cruz Biotechnology公司的SHP-1多克隆抗体进行免疫印迹实验。 更多
SHP-2 (SHP-2)
protein tyrosine phosphatase non-receptor type 11
总数:34
Autoamplification of Notch signaling in macrophages by TLR-induced and RBP-J-dependent induction of Jagged1. 2010 至该文献
为了研究在巨噬细胞中TLR和RBP-J对Notch信号自发放大的调节作用，采用Santa Cruz Biotechnology公司多克隆抗Shp2抗体进行了免疫印迹实验。 更多
SOCS3
suppressor of cytokine signaling 3
总数:10
Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts. 2009 至该文献
为了研究已故捐献者DD)和活人捐献者(LD)肝脏移植在分子水平上的显著差异，采用了Santa Cruz Biotech公司的SOCS3抗体，进行了免疫组织化学实验。 更多
SP100
SP100 nuclear antigen
总数:4
Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins. 2009 至该文献
为了研究HP1蛋白在p53/p21诱导的端粒酶关联的PML小体的延长中所起的作用，使用了Millipore公司的抗Sp100抗体来进行免疫组化分析。 更多
信号传导子及转录激活子1 (STAT1)
signal transducer and activator of transcription 1
总数:84
T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response. 2010 至该文献
为了研究富于T细胞/组织细胞的B细胞淋巴瘤的基因转录特征，采用了Santa Cruz Biotechnology的抗STAT1抗体进行免疫组织化学实验。 更多
SUMO-1 (SUMO-1)
small ubiquitin like modifier 1
总数:40
A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. 2012 至该文献
为了研究myc依赖的癌症需要SUMO化修饰来促进肿瘤发生，采用Abcam的抗SUMO1抗体进行蛋白印迹实验。 更多
VCAM-1 (VCAM-1)
vascular cell adhesion molecule 1
总数:19
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways. 2009 至该文献
为研究前列腺特异膜抗原在前列腺癌细胞的白介素6和CCL5的表达调控中所发挥的角色，将Immunotech提供的抗血管细胞粘附分子抗体用于阻断或激活实验中。 更多